PROGRAM. 43 rd Annual Meeting German Society for Immunology 43. Jahrestagung der Deutschen Gesellschaft für Immunologie (DGfI)

Size: px
Start display at page:

Download "PROGRAM. 43 rd Annual Meeting German Society for Immunology 43. Jahrestagung der Deutschen Gesellschaft für Immunologie (DGfI)"

Transcription

1 43 rd Annual Meeting German Society for Immunology 43. Jahrestagung der Deutschen Gesellschaft für Immunologie (DGfI) September 2013 Mainz Peter Pulkowski PROGRAM

2 44 th Annual Meeting German Society for Immunology Chairs Prof. Dr. Gunther Hartmann Institute of Clinical Chemistry and Clinical Pharmacology September 2014 WORLD CONFERENCE CENTER BONN and Prof. Dr. Christian Kurts Institutes of Molecular Medicine and Experimental Immunology Rheinische Friedrich-Wilhelms-University Sigmund-Freud-Straße Bonn (DE) Symposia Antigen cross-presentation Inflammasome Nucleic acid immune sensing Sessions Allergy and autoimmunity Barrier immunity B cells and antibodies Cancer and inflammation Cell migration, communication and signaling Emerging topics Immune responses to infections Translational and clinical immunology Young immunologists Information and registration at

3 Table of contents Organization and Imprint... 4 Welcome Note of the Conference Chairs... 6 Key of Workshops and Abstract Topics... 7 Invitation to the General Assembly of the DGfI... 8 General Information Map of Public Transport, Campus Plan General Tips for Authors and Presenters Program Overview Wednesday, 11 September Thursday, 12 September Friday, 13 September Saturday, 14 September Satellite Symposium Joint Symposium DGfI-AKTI in association with DGI Symposium DGfI-AKTuI Scientific Program Wednesday, 11 September Thursday, 12 September Friday, 13 September Saturday, 14 September Poster Sessions Poster Session 1 Thursday, 12 September Poster Session 2 Thursday, 12 September Poster Session 3 Friday, 13 September Poster Session 4 Friday, 13 September Sponsors Exhibitors Plan of Exhibition Area Philosophicum Media Cooperations Social Program Index of Chairs, Invited Speakers and Presenting Abstract Authors

4 Organization and Imprint Venue University of Mainz Muschel, Philosophicum, ReWi Saarstrasse Mainz (DE) Date September 2013 Conference Website Organiser German Society for Immunology e. V. (DGfI) Conference Chairs Prof. Dr. Ari Waisman University Medical Center Mainz Institute of Molecular Medicine Hochhaus am Augustusplatz Obere Zahlbacher Strasse Mainz (DE) Prof. Dr. Hansjörg Schild University Medical Center Mainz Institute for Immunology Langenbeckstrasse Mainz (DE) Conference Organisation and Industrial Exhibition Conventus Congressmanagement & Marketing GmbH Nadia Al-Hamadi Carl-Pulfrich-Strasse Jena (DE) Phone Fax Design/Layout Layout design.de Print Circulation Editorial Deadline 30 August

5 Special prepublication offer: CHF 90. / EUR 75. / USD Angiogenesis, Lymphangiogenesis and Clinical Implications Coming soon! Editors: Gianni Marone and Francescopaolo Granata (Naples) Articles in this book deal with the emerging, intriguing possibility that immune cells are both a source and a target of angiogenic and lymphangiogenic factors. This volume will be of broad interest to scientists interested in vascular biology, to basic and clinical immunologists, to oncologists and to specialists in allergic and immune disorders. Angiogenesis, Lymphangiogenesis and Clinical Implications (Chemical Immunology and Allergy, Vol. 99) Editors: Marone, G.; Granata, F. (Naples) approx. 200 p., hard cover, 2013 Special prepublication price: CHF 90. / EUR 75. / USD Prices subject to change EUR price for Germany, USD price for USA only ISBN (hard cover) The easiest way to order: Use the promotional code KI13273P Tentative Contents History of Research on Angiogenesis: D. Ribatti Immune Cells as Source and Target of Angio genic and Lymphangiogenic Factors: G. Marone, S. Loffredo, R.I. Staiano, F. Granata, A. Genovese Neuropilins: Role in Signalling, Angiogenesis and Disease: Zachary, I. Class 3 Semaphorin in Angiogenesis and Lymphangiogenesis: F. Bussolino, E. Giraudo, G. Serini Angiogenic and Anti-Angiogenic Chemokines: S. Sozzani, D. Bosisio, V. Salvi, V. Gagliostro Role of upa/upar in the Modulation of Angio genesis: N. Montuori, P. Ragno Neutrophil-Derived Cytokines Involved in Physiological and Pathological Angiogenesis: A. Cassatella, C. Tecchio The Roles of Eosinophils in the Modulation of Angiogenesis: H. Nissim, B. Efraim, F. Levi-Schaffer Treg Cells, Leptin and Angiogenesis: G. Matarese, V. Pucino, V. de Rosa, C. Proccacini Angiogenesis as a Therapeutic Target for Obesity and Metabolic Diseases: Y. Cao Angiogenesis in Multiple Myeloma: A. Vacca, R. Ria, A. Reale, D. Ribatti Angiogenesis Inhibitors in the Treatment of Prostate Cancer: B.A. Adesunloye, F.H. Karzai, W. L. Dahut Therapeutic Perspectives in Vascular Remodelling in Asthma and COPD: D. Olivieri, A. Chetta KI

6 Welcome Note of the Conference Chairs Dear colleagues and friends, On behalf of the board of the German Society for Immunology (DGfI) we are delighted to invite you to participate in our 43 rd Annual Meeting to be held in Mainz, Germany from September The conference will take place on the University s campus and bring together about students and professionals from academia, industry and government organisations. During main symposia and plenary sessions, an international and national delegation of renowned scientists, will present and discuss the stated main topics of basic and translational immunological research Tolerance, T cell plasticity (transcriptional regulation of immune cells), APC/T-cell interaction, Signaling, Pattern recognition, Controlling immune responses, Autoimmunity, B cells, Immune organogenesis, Innate effector cells, Tumor immunology, Gut (mucosal immunity). The lovely city of Mainz will certainly provide the perfect frame for an unforgettable event. We hope to see you all in September 2013 in Mainz! Yours Conference Chairs Ari Waisman Hansjörg Schild 6

7 Key of Workshops and Abstract Topics Workshop/abstract topic Abstract ID Pages Adhesion Molecules Autoimmunity ff. B Cells ff. Clinical Immunology, Immunodeficiencies, Reproduction Immunology ff. Complement and Fc Receptors f. Dendritic Cells ff. Effector Function of T Cells ff. Granulozytes, Mast Cells, Immune Response in the Skin , ff. Infection Immunology , , ff., 81 ff., 89 ff. Lymphocyte Activation ff. Macrophages ff. Mechanism of Tolerance induced by T Cells f. Mucosal Immunology ff. NK, Gamma Delta, NK T Cells f. Signal Crosstalk, Signaltransduction, Calcium Signaling ff. T helper Cell Differentiation ff. Transplantation Immunology ff. Tumor Immunology , ff. Vaccination and Immune Memory ff. Veterinary Immunology

8 Invitation to the General Assembly of the DGfI Thursday, 12 September 2013, University Mainz N01/Muschel Dear Members of the German Society for Immunology, on behalf of the DGfI board we invite you to our 2013 General Members Assembly. Please find the agenda below. Agenda TOP 1 Approval of the agenda TOP 2 Approval of the minutes of the last general assembly of 07 September 2012 (see members area) TOP 3 Report of the President Overview over DGfI activities 2012/2013/2014 TOP 4 Report of the General Secretary Development of member statistics Financial report (Annual accounts 2012) Travel grants Central office TOP 5 TOP 6 TOP 7 TOP 8 TOP 9 TOP 10 TOP 11 TOP 12 Discharge of the board Academy of Immunology (Education Committee) Spring School Autumn School School of Translational Immunology Consultant Immunologist of the DGfI Appointment of the commission Consultant Immunologist Activities of the study groups Upcoming meetings DGfI Annual Meeting 2013 Mainz DGfI Annual Meeting 2014 Bonn ECI2015 Vienna DGfI Annual Meeting years DGfI in 2017 ICI2019 Berlin DGfI bid Public outreach activities Update Immunology in Germany Project Immunology for Everyone Awards of the DGfI Umbrella organisations vbio IUIS AOB We are looking forward to your participation. With kind regards, Prof. Dr. Carsten Watzl Secretary General 8

9 Weitere Informationen finden Sie unter Wer träumt nicht von einer Innovation mit raschem Wirkeintritt und Langzeiteffekt? Direkt aus dem Porsche Entwicklungszentrum in Weissach: der neue Panamera S E-Hybrid, weltweit erster Plug-in-Hybrid in der Luxusklasse. Kraftstoffverbrauch (in l/100 km) kombiniert 3,1; CO 2 -Emissionen 71 g/km; Stromverbrauch 16,2 kwh/100 km Innovation_148x210_Viszeral_Medizinkongress.indd :59 89

10 General Information Registration Fees Conference fee (all days) Member DGfI Regular Member DGfI Student* Non member Regular Non member Student* 320 EUR 120 EUR 400 EUR 150 EUR Day ticket fees 12 Sep Sep Sep Member DGfI Regular 120 EUR 120 EUR 85 EUR Member DGfI Student* 50 EUR 50 EUR 30 EUR Non member Regular 150 EUR 150 EUR 130 EUR Non member Student* 60 EUR 60 EUR 40 EUR Social Program Welcome Reception, 11 September 2013 regular and student* incl. Welcome Reception, 11 September 2013 accompanying person 15 EUR Social Evening, 13 September 2013 fully booked * Please provide proof of status via at or via fax and quote DGfI. General terms and conditions Please find our general terms and conditions on the conference website List of Attendants Please remember to sign the list of attendants (with barcode, if required or applicable) which is at the Check-In. Certificate of Attendance Certificates of attendance are available on your last day of the conference at the Check-In. Education Credits and Certification The 43 rd Annual Meeting German Society for Immunology (DGfI) is certified with 18 CME points (category B) by the Landesärztekammer Rheinland-Pfalz. Scientific Program Thursday, 12 September CME points category B Friday, 13 September CME points category B Saturday, 14 September CME points category B For certification all attendants are required to daily sign the certification list near the Check-In. 10

11 General Information Opening Hours Wednesday Thursday Friday Saturday Check-In hrs hrs hrs hrs Media Check-In hrs hrs hrs hrs Industrial Exhibition hrs hrs hrs hrs Abstract Volume The abstracts of the DGfI meeting are published on a USB flash drive. Participants receive it at the Check-In free of charge. Prior to the conference all abstracts will also be available online on Internet There are computers with internet access available at the Internet Lounge sponsored by Dr. Ing. h. c. F. Porsche AG. Wireless internet will also be accessible free of charge. The code will be handed out at the Check-In. Poster Prizes The five best posters will be awarded with 500 EUR. The awards will be presented after the last plenary sessions on Saturday, 14 September, 2013 from hrs. All potential awardees will be informed on time and are kindly asked to attend. The prizes are sponsored by: Research Center for Immunology (FZI) PeproTech GmbH R&D Systems GmbH FZI Forschungs- Zentrum Immunologie Evaluation Please turn in your completed and legible evaluation form to the Info Desk or Check-In on the last day. We are looking forward to your active participation and constructive criticism. Catering During the coffee breaks, industrial exhibition free coffee, tea, water and snacks will be provided at the points marked Catering on the ground and first floor of the Philosophicum (see page 115). During lunch breaks coffee, tea and water is served free of charge at the indicated areas. Furthermore lunch is served during the breaks. Alternatively you have the option to have lunch on campus in the canteen (Mensa; hrs) or several cafeterias, serving warm dishes for reasonable prices. Please note, that the canteen only accepts cash at Theke 4. (follow the signs on site). For a better orientation, please have a look at page

12 General Information Cloakroom The cloakroom is in the fi rst fl oor of the Philosophicum (costs: 50 cent per piece). Local Transport The easiest way to reach the Mainz University is to take one of the following bus lines from Mainz main station ( Hauptbahnhof ) Line 6 (direction Marienborn ) Line 6A (direction Bretzenheim/Gutenberg-Center ) Line 54 (direction Lerchenberg/Brucknerstraße ) Please get out at following bus stops Universität (main entrance, Forum universitatis) Friedrich-von-Pfeiffer-Weg (Philosophicum) Ackermannweg (main car entrance) Every participant receives a free ticket for the public transport in Mainz for the entire period of the conference (11 14 September 2013). Participants who registered and paid until 21 August, 2013, received the namebadge and ticket for local transport prior to the conference via mail. Participants registering and paying later that 21 August, 2013, will receive the documents directly at the Check-In. The ticket is valid for all lines in the RMV-tariff area 65 (including Mainz and Wiesbaden plus following parts of the town: Zornheim, Wackernheim, Walluf, Wallgau, Hochheim, Bischofsheim and Ginsheim-Gustavsburg). For schedule information please have a look at Parking The University Campus offers several area for parking. Please leave, clearly visible, a fl yer of the DGfI conference in the front window of your vehicle. Flyers are available at the Check-In in the Philosophicum. 12

13 in Germany Celebrating the occasion of the 43 rd Annual Meeting of the German Society for Immunology (DGfI), September 2013, International Immunology has compiled a special article collection highlighting work published recently by German researchers in the journal. Differential regulation of marginal zone and follicular B cell responses by CD83 Melanie Uhde, Svenja Kuehl, Ulricke Richardt et al. Advance Access DOI /intimm/dxt021 Mast cell-derived mediators promote murine neutrophil effector functions Fatma Doener, Anastasija Michel, Sebastian Reuter, et al. Advance Access DOI /intimm/dxt019 Abrogation of IL-4 receptor-α-dependent alternatively activated macrophages is sufficient to confer resistance against pulmonary cryptococcosis despite an ongoing Th2 response Uwe Müller, Werner Stenzel, Daniel Piehler, et al. Advance Access DOI /intimm/dxt003 Histamine 4 receptor plays an important role in auto-antibody-induced arthritis Elisa Nent, David Frommholz, Mieczyslaw Gajda, et al. Volume 25 Issue 7 (2013) Vav1 regulates MHCII expression in murine resting and activated B cells Bettina Jux, Andrea Staratschek-Jox, Josef M. Penninger, et al. Volume 25 Issue 5 (2013) Targeting the antigen encoded by adenoviral vectors to the DEC205 receptor modulates the cellular and humoral immune response Matthias Tenbusch, Godwin Nchinda, Michael Storcksdieck Genannt Bonsmann, et al. Volume 25 Issue 4 (2013) In the presence of IL-21 human cord blood T cells differentiate to IL-10-producing Th1 but not Th17 or Th2 cells Aysefa Doganci, Julia Birkholz, Stephan Gehring, et al. Volume 25 Issue 3 (2013) Trafficking of regulatory T cells in the intestinal immune system Oliver Pabst Volume 25 Issue 3 (2013) Establishment of the reversible peptidemajor histocompatibility complex (pmhc) class I Histamer technology: tool for visualization and selection of functionally active antigen-specific CD8 T lymphocytes Sabine Tischer, Till Kaireit, Constança Figueiredo, et al. Volume 24 Issue 9 (2012) HMGB1 conveys immunosuppressive characteristics on regulatory and conventional T cells Clarissa Anni Wild, Christoph Bergmann, Günter Fritz, et al. Volume 24 Issue 8 (2012) Visit us online to read the articles for FREE at: INTIMM_German.indd 1 7/25/13 9:32 AM 12 13

14 General Information Map of Public Transport Alte Lokhalle Fr.-v.-Pfeiffer-Weg Universität Ackermannweg/FH 14

15 66. Jahrestagung der Deutschen Gesellschaft für Hygiene und Mikrobiologie (DGHM) und Jahrestagung der Vereinigung für Allgemeine und Angewandte Mikrobiologie (VAAM) JOINT MEETING Fotolia/digi dresden SEPTEMBER/OKTOBER 2014 DRESDEN Kongresspräsidenten Prof. Dr. Gerold Barth und Prof. Dr. Volkhard Kempf

16 City Center General Information Campus Plan Forum Universitatis Bus stop Fr.-v.-Pfeiffer-Weg Bus stop Fr.-v.-Pfeiffer-Weg Bus stop Universität Bus stop Universität Important Points Johannes Gutenberg University Mainz Bus stop Ackermannweg University Mainz 16

17 16 17

18 General Tips for Authors and Presenters Submitting Your Presentation Please prepare your presentation in 4:3 aspect ratio. A presentation notebook with a PDF reader and MS Office PowerPoint 2007 will be provided. The use of personal notebooks is possible a technical supervisor will help you. Please provide an adapter for VGA if necessary. A notebook, presenter and laser pointer are available at the speaker s podium in the lecture hall. Media Check-In The media check-in is located on the first floor of the Philosophicum and is sponsored by Dr. Ing. h. c. F. Porsche AG. Please submit your presentation on the day before your presentation, but no later than 2 hours before your presentation. You will have the possibility to view and edit your presentation on-site. For submission, please use a USB flash drive which should not be protected with software. Time allotment Invited speaker presentations have been fixed to 25+5 minutes for discussion. The length of an oral abstract presentation is 10+5 minutes for discussion. To ensure the smooth running of the entire program, all speakers are requested to adhere to their allocated speaking time. The session chairs are encouraged to inform the speaker of any delays. Poster Sessions The poster sessions are scheduled on Thursday, 12 September 2013 and Friday, 13 September 2013 from hrs and from hrs. The following poster presentations will be held during the sessions: Poster Session 1 Thursday, 12 September 2013 ( hrs) 1 50 Autoimmunity 1+2 (see pages 64 ff.) B Cells (see pages 68 ff.) Infection Immunology 1 (see pages 70 ff.) Lymphocyte Activation 1+2 (see pages 72 ff.) Signal Crosstalk, Signaltransduction, Calcium Signaling (see pages 75 ff.) Poster Session 2 Thursday, 12 September 2013 ( hrs) Dendritic Cells 1+2 (see pages 77 ff.) Infection Immunology 2 (see pages 81 ff.) Mucosal Immunology 1+2 (see pages 83 ff.) T helper Cell Differentiation (see pages 86 ff.) 18

19 General Tips for Authors and Presenters Poster Session 3 Friday, 13 September 2013 ( hrs) Adhesion Molecules (see page 88) Complement and Fc Receptors (see pages 88 f.) Infection Immunology 3 (see pages 89 ff.) Mechanism of Tolerance Induced by T Cells (see pages 91 f.) Transplantation Immunology (see pages 92 ff.) , 581 Tumor Immunology (see pages 94 ff.) Vaccination and Immune Memory (see pages 97 ff.) Poster Session 4 Friday, 13 September 2013 ( hrs) Clinical Immunology, Immunodeficiencies, Reproduction Immunology (see pages 100 ff.) Effector Function of T Cells (see pages 103 ff.) , Granulocytes, Mast Cells, Immune Response in the Skin (see pages 105 f.) Macrophages 1+2 (see pages 106 ff.) NK, Gamma Delta, NK T Cells (see pages 109 f.) Veterinary Immunology (see page 110) Posters should be DIN A0 (84.1 cm x cm). Poster pin boards are 120cm x 150cm. They are only to be used with the designated pins. Pin boards will be numbered. Keep in mind It is recommended to all poster authors to hang their posters on the dates and times stated below. Presenting authors are kindly asked to attend to their poster during the assigned session. Poster Session 1: Wednesday, 11 September from hrs until Thursday, 12 September hrs Poster Session 2: Wednesday, 11 September from hrs until Thursday, 12 September hrs Poster Session 3: Friday, 13 September from hrs until Saturday, 14 September hrs Poster Session 4: Friday, 13 September from hrs until Saturday, 14 September hrs Posters should be removed no later than hrs on 14 September, Posters will not be redirected

20 Program Overview Wednesday, 11 September 2013 ReWi Philosophicum R1 P10 P11 Foyer 12:30 15:45 Joint Symposium German Society for Immunology/Working Group Transplant Immunology (DGfI AKTI) and the German Society for Immunogenetics (DGI) 12:00 15:45 Symposium German Society for Immunology/Working Group Tumor Immunology (DGfI-AKTuI) p. 25 p :00 18:00 DGfI President s Symposium 18:00 19:00 Opening Ceremony p :00 21:00 Welcome Reception p. 117 Key Main Symposium Plenary Session Workshop Poster Session Sessions of the DGfI Industrial Symposium Social Program 20

21 Muschel Program Overview Thursday, 12 September 2013 Philosophicum N01 N02 N03 P2 P10 P11 08:30 10:00 Tolerance Please note that the symposium takes place in the ReWi, Room R1. Industrial exhibition and coffee break (Philosophicum) p :30 12:00 10:30 12:00 10:30 12:00 10:30 12:00 10:30 12:00 10:30 12:00 Infection Immunology 1 Autoimmunity 1 B Cells Lymphocyte Activation 1 Mucosal Immunology 1 Signal Crosstalk, Signaltransduction, Calcium Signaling p. 30 p. 31 p. 32 p. 33 p. 34 p. 35 Industrial exhibition and lunch break (Philosophicum) 12:00 13:00 12:00 13:00 13:00 14:30 13:00 14:30 13:00 14:30 B Cells Signalling Controlling Immune Responses Bio Rad Laboratories Ltd Nanostring Technologies Europe LTD p. 36 p. 36 p. 36 p. 37 p :30 16:00 Poster Session 1 (Philosophicum) Autoimmunity 1+2 B Cells Infection Immunology 1 Lymphocyte Activation 1+2 Signal Crosstalk Signaltransduction, Calcium Signalling p. 64 ff. 16:00 17:30 16:00 17:30 16:00 17:30 16:00 17:30 16:00 17:30 16:00 17:30 Autoimmunity 2 Dendritic Cells 1 Mucosal Immunology 2 T helper Cell Differentiation Macrophages 1 Lymphocyte Activation 2 p. 38 p. 39 p. 40 p. 41 p. 42 p :30 19:00 Poster Session 2 (Philosophicum) Dendritic Cells 1+2 Infection Immunology 2 Mucosal Immunology 1+2 T helper Cell Differentiation 19:00 20:00 General Assembly of the DGfI p. 77 ff. p

22 Program Overview Friday, 13 September 2013 Muschel Philosophicum N01 N02 N03 P2 P10 P11 08:30 10:00 APC/T Cell Interaction Please note that the symposium takes place in the ReWi, Room R1. Industrial exhibition and coffee break (Philosophicum) p :30 12:00 10:30 12:00 10:30 12:00 10:30 12:00 10:30 12:00 10:30 12:00 Transplantation Tumor Escape and Dendritic Cells 2 Immunology Tumor Micromillieu Mechanism of Tolerance Induced by T Cells CIMT: Antibodies and their Targets in Cancer Therapy Vaccination and Immune Memory p. 44 p. 45 p. 46 p. 47 p. 48 p. 49 Industrial exhibition and lunch break (Philosophicum) 12:00 13:00 12:00 13:00 12:00 13:00 13:00 14:30 13:00 14:30 13:00 14:30 Autoimmunity Immune Pattern Recognition Organogenesis Hiss Diagnostics GmbH pluriselect GmbH Lunch Seminar DFG and EJI p. 49 p. 50 Lunch Seminar Molecular Imaging in Immunology p. 50 p. 51 p. 51 p :30 16:00 Poster Session 3 (Philosophicum) Complement and Fc Receptors Infection Immunology 3 Mechanism of Tolerance induced by T Cells Transplantation Immunology Tumor Immunology Vaccination and Immune Memory p. 88 ff. 16:00 17:30 16:00 17:30 16:00 17:30 16:00 17:30 16:00 17:30 Infection Effector Function of CIMT: Therapeutic Clinical NK, Gamma Delta, Immunology 2 T Cells Tumor Vaccination Immunology NK T Cells p. 52 p. 53 p. 54 p. 55 p :30 19:00 Poster Session 4 (Philosophicum) Clinical immunology, Immunodefi ciencies, Reproduction Immunology Effector Function of T Cells Granulozytes, Mast Cells, Immune Response in the Skin Macrophages 1+2 NK, Gamma Delta, NK T Cells Veterinary Immunology 19:00 23:00 Social Evening Alte Lokhalle p. 100 ff. p

23 Muschel Philosophicum N01 N02 N03 P10 P11 08:30 10:00 T Cell Plasticity (Transcriptional Regulation of Immune Cells) Please note that the symposium takes place in the ReWi, Room R1. Program Overview Saturday, 14 September 2013 Industrial exhibition and coffee break (Philosophicum) p :30 12:00 10:30 12:00 10:30 12:00 10:30 12:00 10:30 12:00 Infection Macrophages 2 Complement and Fc Immunology 3 Receptors Clinical Immunology, Immunodeficiencies, Reproduction Immunology Granulozytes, Mast Cells, Immune Response in the Skin p. 58 p. 59 p. 60 p. 61 p. 62 Industrial exhibition and lunch break (Philosophicum) 12:30 14:00 12:30 14:00 12:30 14:00 Innate Effector Cells CIMT: New Concepts in Gut (Mucosal Immunity) Cancer Immunotherapy p. 63 p. 63 p :00 15:30 Awards, Poster Prizes and Closing Remarks Key Main Symposium Plenary Session Workshop Poster Session Sessions of the DGfI Industrial Symposium Social Program 22 23

24 Satellite Symposium Joint Symposium DGfI-AKTI (Transplant Immunology) in association with DGI German Society for Immunology/Working Group Transplant Immunology (DGfI-AKTI) in association with the German Society for Immunogenetics (DGI) New concepts to establish and monitor individualized therapy protocols in allograft recipients Not every patient has the same immune status when he receives an organ allograft and not every patient requires the same amount of immunosuppressive drugs after transplantation. Therefore, the establishment of immunomodulatory therapies which are guided by patient-specific conditions is a major goal in transplantation medicine. New concepts of individualized therapies have recently been developed, based on research in the fields of Transplantation Immunology and Immunogenetics. Experts from both fields will contribute to the scientific discussion on the significance of individualized therapy in transplantation and give an overview on the current status. The joint symposium is addressed to basic scientists, translational researchers, and physicians interested in applied aspects of transplantation biology/immunology. The topics presented will focus on patient monitoring to assess the individual risk for rejection/infection and the development of tolerance after transplantation. Furthermore, new strategies will be discussed to achieve donor-specific nonreactivity/tolerance in clinical organ transplantation by means of cellular therapy Monitoring Aspects P10/Philosophicum Chairs Caner Süsal (Heidelberg), Reinhard Schwinzer (Hannover) Biomarkers for tolerance/rejection Birgit Sawitzki (Berlin) Pre- and posttransplant antibody monitoring in heart transplantation Teresa Kauke (Munich) An integrative algorithm for the successful transplantation of highly immunized kidney transplant recipients Caner Süsal (Heidelberg) Assessment of donor-specific adaptation in kidney grafted patients Reinhard Schwinzer (Hannover) Coffee break 24

25 Satellite Symposium Joint Symposium DGfI-AKTI (Transplant Immunology) in association with DGI Cellular Therapy and Risk Factors P10/Philosophicum Chairs Caner Süsal (Heidelberg), Reinhard Schwinzer (Hannover) Immunomodulation using regulatory macrophages James Hutchinson (Regensburg) Treg in organ transplantation Elmar Jäckel (Hannover) Mesenchymal stem cells for therapy Marc Dahlke (Regensburg) Differential immunogenicity of HLA antigen epitopes Nils Lachmann (Berlin) Complement in organ transplantation Michael Kirschfink (Heidelberg) 24 25

26 Satellite Symposium Symposium DGfI-AKTuI (Tumor Immunology) Tumor Immunology P11/Philosophicum Chairs Barbara Seliger (Halle/Saale), Michael Bachmann (Dresden) Welcome and Introduction Elfriede Noessner (Munich) Engineered mesenchymal stem cells as a therapeutic modality for the treatment of solid tumors Peter Nelson (Munich) From single to universal BiTEs and CARs for individual Immunotherapy the past, presence and future Michael Bachmann (Dresden) Combinatorial antigen recognition by dual CAR T cells for use in adoptive cell therapy Tobias Riet, Astrid Holzinger (Cologne) Intratumoral T cells in a spontaneous lymphoma model Tanja Riedel (Munich) Break Imiquimod and resiquimod efficiently improve the immunestimulatory properties of human 6-sulfo LacNAc dendritic cells Rebecca Wehner (Dresden) Role of micrornas in the regulation of HLA class I abnormalities in tumor cells Barbara Seliger (Halle/Saale) Dysfunction of lymphocytes infiltrating human renal cell carcinoma displays anergic features and reveals diacylglycerol kinase and the ERK pathway as targets for therapeutic intervention Elfriede Noessner (Munich) RIG-I initiated innate immune signaling in melanoma cells enhance their sensitivity towards T cells, but not NK cells Lina Spaan (Essen) Concluding remarks Michael Bachmann (Dresden) 26

27 Research tools for the most demanding immunology experiments Antibody arrays: HTP platform to profile protein expression Cytokines: Active proteins with low endotoxin levels and batch to batch consistency Flow cytometry validated monoclonals: Wide coverage of both surface and intracellular targets SimpleStep ELISA: Single wash sandwich ELISA kit Just mix, wash and read Discover more at abcam.com 262_13_JH 26 27

28 Scientific Program Wednesday, 11 September DGfI President s Symposium R1/ReWi Chairs Dieter Kabelitz (Kiel), Jürgen Wienands (Göttingen) Welcome Hans-Martin Jäck (Erlangen) Key Note 1 Retroelements in autoimmunity Matthias Wabl (San Francisco, CA/US) IS 1 IS 2 IS 3 IS 4 IS 5 Hans-Hench Awardee Separation from self explains failure of circulating T-cells to respond to the CD28 superagonist TGN1412 Paula Romer-Roche (Würzburg) Herbert-Fischer Awardee Microglia emerge from erythromyeloid precursors via Pu.1 - and Irf8-dependent pathways Katrin Kierdorf (Freiburg) Otto-Westphal Awardee prize is sponsored by Dr. Ing. h. c. F. Porsche AG Aryl hydrocarbon receptor signaling controls organogenesis of intestinal lymphoid follicles Elina Kiss (Freiburg) Fritz-and-Ursula Melchers Awardee Thymus autonomous T cell development Vera Martins (Ulm) Georges-Köhler Awardee prize is sponsored by Dr. Ing. h. c. F. Porsche AG Lipid oxidation at the interface of innate and adaptive immunity Gerhard Krönke (Erlangen) IS 6 Key Note 2 Sein und Dasein in B cell development Fritz Melchers (Berlin) Opening Ceremony from Welcome Reception (see page 117) Philosophicum 28

The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor

The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor The immune system Basophil Neutrophil Bone marrow Eosinophil Myeloid progenitor Dendritic cell Pluripotent Stem cell Lymphoid progenitor Platelets Bone marrow Thymus NK cell T-cell B-cell Spleen Cancer

More information

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins

specific B cells Humoral immunity lymphocytes antibodies B cells bone marrow Cell-mediated immunity: T cells antibodies proteins Adaptive Immunity Chapter 17: Adaptive (specific) Immunity Bio 139 Dr. Amy Rogers Host defenses that are specific to a particular infectious agent Can be innate or genetic for humans as a group: most microbes

More information

Autoimmunity and immunemediated. FOCiS. Lecture outline

Autoimmunity and immunemediated. FOCiS. Lecture outline 1 Autoimmunity and immunemediated inflammatory diseases Abul K. Abbas, MD UCSF FOCiS 2 Lecture outline Pathogenesis of autoimmunity: why selftolerance fails Genetics of autoimmune diseases Therapeutic

More information

Chapter 17A: Adaptive Immunity Part I

Chapter 17A: Adaptive Immunity Part I Chapter 17A: Adaptive Immunity Part I 1. Overview of Adaptive Immunity 2. T and B Cell Production 3. Antigens & Antigen Presentation 4. Helper T cells 1. Overview of Adaptive Immunity The Nature of Adaptive

More information

3 rd B Cell Forum March 17 to 19, 2005 Bad Breisig, Germany Germany. Germany

3 rd B Cell Forum March 17 to 19, 2005 Bad Breisig, Germany Germany. Germany 3 rd B Cell Forum March 17 to 19, 2005 Bad Breisig, Germany Germany Germany Preliminary Program 3 rd Forum B Cell Biology Bad Breisig, 17-19 March 2005 Organizing committee: Ari Waisman Markus Müschen

More information

Microbiology AN INTRODUCTION EIGHTH EDITION

Microbiology AN INTRODUCTION EIGHTH EDITION TORTORA FUNKE CASE Microbiology AN INTRODUCTION EIGHTH EDITION Differentiate between innate and acquired immunity. Chapter 17 Specific Defenses of the Host: The Immune Response B.E Pruitt & Jane J. Stein

More information

2 nd Forum B Cell Biology

2 nd Forum B Cell Biology Preliminary Program 2 nd Forum B Cell Biology Potsdam, 11-13 March 2004 local organizing committee: Claudia Berek Hilmar Frank Falk Hiepe Rudolf A. Manz Marion Nowak Petra Starke Andreas Radbruch Christine

More information

Chapter 43: The Immune System

Chapter 43: The Immune System Name Period Our students consider this chapter to be a particularly challenging and important one. Expect to work your way slowly through the first three concepts. Take particular care with Concepts 43.2

More information

Asthma (With a little SCID to start) Disclosures Outline Starting with the Immune System The Innate Immune System The Adaptive Immune System

Asthma (With a little SCID to start) Disclosures Outline Starting with the Immune System The Innate Immune System The Adaptive Immune System 1 2 3 4 5 6 7 8 9 Asthma (With a little SCID to start) Lauren Smith, MD CHKD Pediatric Allergy/Immunology Disclosures None Will be discussing some medications that are not yet FDA approved Outline SCID

More information

B Cells and Antibodies

B Cells and Antibodies B Cells and Antibodies Andrew Lichtman, MD PhD Brigham and Women's Hospital Harvard Medical School Lecture outline Functions of antibodies B cell activation; the role of helper T cells in antibody production

More information

PROGRAMM. 1. Forum Biologie der B- Lymphozyten" Tagungsstätte: in Titisee 13.-16. März, 2002

PROGRAMM. 1. Forum Biologie der B- Lymphozyten Tagungsstätte: in Titisee 13.-16. März, 2002 PROGRAMM 1. Forum Biologie der B- Lymphozyten" in Titisee 13.-16. März, 2002 Tagungsstätte: Hotel Brugger am See Strandbadstr. 14 79822 Titisee-Neustadt Telefon 07651/8010 Telefax 07651/8238 E-Mail: hotel.brugger@t-online.de

More information

Activation and effector functions of HMI

Activation and effector functions of HMI Activation and effector functions of HMI Hathairat Thananchai, DPhil Department of Microbiology Faculty of Medicine Chiang Mai University 25 August 2015 ว ตถ ประสงค หล งจากช วโมงบรรยายน แล วน กศ กษาสามารถ

More information

The Body s Defenses CHAPTER 24

The Body s Defenses CHAPTER 24 CHAPTER 24 The Body s Defenses PowerPoint Lectures for Essential Biology, Third Edition Neil Campbell, Jane Reece, and Eric Simon Essential Biology with Physiology, Second Edition Neil Campbell, Jane Reece,

More information

ANIMALS FORM & FUNCTION BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES. Animals Form & Function Activity #4 page 1

ANIMALS FORM & FUNCTION BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES. Animals Form & Function Activity #4 page 1 AP BIOLOGY ANIMALS FORM & FUNCTION ACTIVITY #4 NAME DATE HOUR BODY DEFENSES NONSPECIFIC DEFENSES PHYSICAL BARRIERS PHAGOCYTES Animals Form & Function Activity #4 page 1 INFLAMMATORY RESPONSE ANTIMICROBIAL

More information

Cancer Immunotherapy: Can Your Immune System Cure Cancer? Steve Emerson, MD, PhD Herbert Irving Comprehensive Cancer Center

Cancer Immunotherapy: Can Your Immune System Cure Cancer? Steve Emerson, MD, PhD Herbert Irving Comprehensive Cancer Center Cancer Immunotherapy: Can Your Immune System Cure Cancer? Steve Emerson, MD, PhD Herbert Irving Comprehensive Cancer Center Bodnar s Law Simple Things are Important Very Simple Things are Very Important

More information

Recognition of T cell epitopes (Abbas Chapter 6)

Recognition of T cell epitopes (Abbas Chapter 6) Recognition of T cell epitopes (Abbas Chapter 6) Functions of different APCs (Abbas Chapter 6)!!! Directon Routes of antigen entry (Abbas Chapter 6) Flow of Information Barrier APCs LNs Sequence of Events

More information

The Immune System: A Tutorial

The Immune System: A Tutorial The Immune System: A Tutorial Modeling and Simulation of Biological Systems 21-366B Shlomo Ta asan Images taken from http://rex.nci.nih.gov/behindthenews/uis/uisframe.htm http://copewithcytokines.de/ The

More information

Summer School 2011 Berlin SFB Transregio 19

Summer School 2011 Berlin SFB Transregio 19 Summer School 2011 Berlin SFB Transregio 19 27th October 29th October 2011 Molecular Mechanisms and Consequences of Inflammatory Cardiomyopathy: State of the Art and Future Challenges Welcome Address

More information

CONTENT. Chapter 1 Review of Literature. List of figures. List of tables

CONTENT. Chapter 1 Review of Literature. List of figures. List of tables Abstract Abbreviations List of figures CONTENT I-VI VII-VIII IX-XII List of tables XIII Chapter 1 Review of Literature 1. Vaccination against intracellular pathogens 1-34 1.1 Role of different immune responses

More information

Human Immunity. How our body s cells defend against microbial and viral invaders

Human Immunity. How our body s cells defend against microbial and viral invaders Human Immunity How our body s cells defend against microbial and viral invaders What is Immunity? The word immunity comes from the Latin immunus meaning free of burden. Thus; it is a body s general ability

More information

Dendritic Cells: A Basic Review *last updated May 2003

Dendritic Cells: A Basic Review *last updated May 2003 *last updated May 2003 Prepared by: Eric Wieder, PhD MD Anderson Cancer Center Houston, TX USA What is a dendritic cell? Dendritic cells are antigen-presenting cells (APCs) which play a critical role in

More information

AN INTRODUCTION TO IMMUNOLOGY. Paul Thomas Unit 1 Department of Immunology St. Jude Children s Research Hospital

AN INTRODUCTION TO IMMUNOLOGY. Paul Thomas Unit 1 Department of Immunology St. Jude Children s Research Hospital AN INTRODUCTION TO IMMUNOLOGY Paul Thomas Unit 1 Department of Immunology St. Jude Children s Research Hospital CATEGORIES OF PATHOGENS Viruses (~0.2 microns) Bacteria (1-2 microns) Parasites (Millimeters)

More information

Microbiology 532 Immunology Examination KEY October 30, 2003

Microbiology 532 Immunology Examination KEY October 30, 2003 KEY October 30, 2003 All questions have equal point value. You may keep the test questions. Multiple Choice (choose the best answer) 1. Receptors associated with innate immunity recognize microbes by detecting:

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: adoptive_immunotherapy 11/1993 3/2016 3/2017 3/2016 Description of Procedure or Service The spontaneous regression

More information

Types of Hypersensitivity. Type I: Allergic Reactions. more on Allergic Reactions

Types of Hypersensitivity. Type I: Allergic Reactions. more on Allergic Reactions Chapter 19: Disorders of the Immune System 1. Hypersensitivity 2. Autoimmunity 3. Transplant Rejection 1. Hypersensitivity What is Hypersensitivity? Hypersensitivity is an immunological state in which

More information

Drug Development Services

Drug Development Services Drug Development Services USING BLOOD AND BONE MARROW PRIMARY CELL SYSTEMS Clinically Relevant In Vitro Assays Broad Spectrum of Drug Classes Multi-Species Platforms Enhancing Drug Development through

More information

ALLIANCE FOR LUPUS RESEARCH AND PFIZER S CENTERS FOR THERAPEUTIC INNOVATION CHALLENGE GRANT PROGRAM PROGRAM GUIDELINES

ALLIANCE FOR LUPUS RESEARCH AND PFIZER S CENTERS FOR THERAPEUTIC INNOVATION CHALLENGE GRANT PROGRAM PROGRAM GUIDELINES ALLIANCE FOR LUPUS RESEARCH AND PFIZER S CENTERS FOR THERAPEUTIC INNOVATION CHALLENGE GRANT PROGRAM PROGRAM GUIDELINES DESCRIPTION OF GRANT MECHANISM The Alliance for Lupus Research (ALR) is an independent,

More information

Name (print) Name (signature) Period. (Total 30 points)

Name (print) Name (signature) Period. (Total 30 points) AP Biology Worksheet Chapter 43 The Immune System Lambdin April 4, 2011 Due Date: Thurs. April 7, 2011 You may use the following: Text Notes Power point Internet One other person in class "On my honor,

More information

A Genetic Analysis of Rheumatoid Arthritis

A Genetic Analysis of Rheumatoid Arthritis A Genetic Analysis of Rheumatoid Arthritis Introduction to Rheumatoid Arthritis: Classification and Diagnosis Rheumatoid arthritis is a chronic inflammatory disorder that affects mainly synovial joints.

More information

TC/DC. Prof. Dr. Albert Duschl

TC/DC. Prof. Dr. Albert Duschl TC/DC Prof. Dr. Albert Duschl Something to think about A number of blockbuster drugs are close to going off-patent soon, or are already off-patent, in other words, available as generic drugs. The most

More information

1) Siderophores are bacterial proteins that compete with animal A) Antibodies. B) Red blood cells. C) Transferrin. D) White blood cells. E) Receptors.

1) Siderophores are bacterial proteins that compete with animal A) Antibodies. B) Red blood cells. C) Transferrin. D) White blood cells. E) Receptors. Prof. Lester s BIOL 210 Practice Exam 4 (There is no answer key. Please do not email or ask me for answers.) Chapters 15, 16, 17, 19, HIV/AIDS, TB, Quorum Sensing 1) Siderophores are bacterial proteins

More information

Midwinter Conference 2015 January 17-22 Seefeld, Tyrol CONFERENCE PROGRAM. midwinter2015.org. Sponsored by

Midwinter Conference 2015 January 17-22 Seefeld, Tyrol CONFERENCE PROGRAM. midwinter2015.org. Sponsored by Midwinter Conference 2015 January 17-22 Seefeld, Tyrol CONFERENCE PROGRAM Sponsored by SATURDAY, 17 January 18.00-19.00 Keynote lecture Richard Flavell Sponsored by 19.00 Welcome Reception Hosted by SUNDAY,

More information

Making the switch to a safer CAR-T cell therapy

Making the switch to a safer CAR-T cell therapy Making the switch to a safer CAR-T cell therapy HaemaLogiX 2015 Technical Journal Club May 24 th 2016 Christina Müller - chimeric antigen receptor = CAR - CAR T cells are generated by lentiviral transduction

More information

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen

Version 1 2015. Module guide. Preliminary document. International Master Program Cardiovascular Science University of Göttingen Version 1 2015 Module guide International Master Program Cardiovascular Science University of Göttingen Part 1 Theoretical modules Synopsis The Master program Cardiovascular Science contains four theoretical

More information

On the origin of giant multinuclear Reed-Sternberg cells and the role of CD4 T cells in Hodgkin lymphoma

On the origin of giant multinuclear Reed-Sternberg cells and the role of CD4 T cells in Hodgkin lymphoma On the origin of giant multinuclear Reed-Sternberg cells and the role of CD4 T cells in Hodgkin lymphoma Uber die Entstehung von multinuklearen Reed-Sternberg Riesenzellen und die Rolle von CD4 T-Zellen

More information

Immuno-Oncology Therapies to Treat Lung Cancer

Immuno-Oncology Therapies to Treat Lung Cancer Immuno-Oncology Therapies to Treat Lung Cancer What you need to know ONCHQ14NP07519 Introduction: Immuno-oncology represents an innovative approach to cancer research that seeks to harness the body s own

More information

HUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES JASON CYSTER SECTION 13

HUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES JASON CYSTER SECTION 13 SECTION 13 HUMORAL IMMUNE RE- SPONSES: ACTIVATION OF B CELLS AND ANTIBODIES CONTACT INFORMATION Jason Cyster, PhD (Email) READING Basic Immunology: Functions and Disorders of the Immune System. Abbas,

More information

B cell activation and Humoral Immunity

B cell activation and Humoral Immunity B cell activation and Humoral Immunity Humoral immunity is mediated by secreted antibodies and its physiological function is defense against extracellular microbes (including viruses) and microbial exotoxins.

More information

The Immunopathogenesis of Relapsing MS

The Immunopathogenesis of Relapsing MS The Immunopathogenesis of Relapsing MS Olaf Stüve, M.D., Ph.D. Neurology Section VA North Texas Health Care System Dallas VA Medical Center Departments of Neurology and Neurotherapeutics University of

More information

JUMISC JUMISC. For further information visit our website:

JUMISC JUMISC. For further information visit our website: STEM CELL THERAPY COMPANY PROFILE & SCIENTIFIC ACTIVITIES For further information visit our website: WWW.CCMIJESUSUSON.COM 20 14 JUMISC JUMISC Carretera N-521, km. 41,8 10071 CÁCERES (SPAIN) Tel. (+34)

More information

ANATOMY OF THE IMMUNE SYSTEM THE IMMUNE SYSTEM. ANATOMY OF THE IMMUNE SYSTEM Thymus glandular organ near the heart where T cells learn their jobs

ANATOMY OF THE IMMUNE SYSTEM THE IMMUNE SYSTEM. ANATOMY OF THE IMMUNE SYSTEM Thymus glandular organ near the heart where T cells learn their jobs THE IMMUNE SYSTEM 1 ANATOMY OF THE IMMUNE SYSTEM 2 We all get sick sometimes...but then we get better. What happens when we get sick? Why do we get better? The immune system is localized in several parts

More information

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press

Gene Therapy. The use of DNA as a drug. Edited by Gavin Brooks. BPharm, PhD, MRPharmS (PP) Pharmaceutical Press Gene Therapy The use of DNA as a drug Edited by Gavin Brooks BPharm, PhD, MRPharmS (PP) Pharmaceutical Press Contents Preface xiii Acknowledgements xv About the editor xvi Contributors xvii An introduction

More information

OVERVIEW OF LECTURE CONTENT: INTRODUCTION AND DEFINITIONS OVERVIEW OF THE LYMPHOCYTE + HISTIOCYTE SUBSETS AND THEIR FUNCTIONS OVERVIEW OF NORMAL LYMPH

OVERVIEW OF LECTURE CONTENT: INTRODUCTION AND DEFINITIONS OVERVIEW OF THE LYMPHOCYTE + HISTIOCYTE SUBSETS AND THEIR FUNCTIONS OVERVIEW OF NORMAL LYMPH AN INTRODUCTION TO THE LYMPHOPROLIFERATIVE DISORDERS BY DR Y PERNER DEPARTMENT OF ANATOMICAL PATHOLOGY OVERVIEW OF LECTURE CONTENT: INTRODUCTION AND DEFINITIONS OVERVIEW OF THE LYMPHOCYTE + HISTIOCYTE

More information

Basics of Immunology

Basics of Immunology Basics of Immunology 2 Basics of Immunology What is the immune system? Biological mechanism for identifying and destroying pathogens within a larger organism. Pathogens: agents that cause disease Bacteria,

More information

10. T and B cells are types of a. endocrine cells. c. lymphocytes. b. platelets. d. complement cells.

10. T and B cells are types of a. endocrine cells. c. lymphocytes. b. platelets. d. complement cells. Virus and Immune System Review Directions: Write your answers on a separate piece of paper. 1. Why does a cut in the skin threaten the body s nonspecific defenses against disease? a. If a cut bleeds, disease-fighting

More information

Lymphatic System - Structures

Lymphatic System - Structures Lymphatic System - Structures Lymphatic vessels Lymphatic tissues and organs 1 Lymphatic System - Functions Returns leaked plasma to blood vessels Cleanses lymph of bacteria & other foreign matter Provides

More information

The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015

The role of IBV proteins in protection: cellular immune responses. COST meeting WG2 + WG3 Budapest, Hungary, 2015 The role of IBV proteins in protection: cellular immune responses COST meeting WG2 + WG3 Budapest, Hungary, 2015 1 Presentation include: Laboratory results Literature summary Role of T cells in response

More information

Welcome to Mini Med School at the Child & Family Research Institute

Welcome to Mini Med School at the Child & Family Research Institute Glossary Welcome to Mini Med School at the Child & Family Research Institute On behalf of the Faculty and Staff at the Child & Family Research Institute (CFRI), we would like to welcome you to CFRI s

More information

How do plasma cells survive

How do plasma cells survive How do plasma cells survive Claudia Berek Deutsches Rheuma Forschungs Zentrum, Berlin Institut der Leibniz Gemeinschaft Immune response Naive B cell Peripheral lymphoid organs Memory B cell Germinal T

More information

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1

1 page Overview. CONCURRENT 1D, 1E, 1F Biology & Pathogenesis Multi-Modality Immunology 1 1 page Overview 21 Oct Tuesday 1500 on REGISTRATION 1800 Welcome Reception & Cocktails at the Cape Town International Conference Centre (CTICC) 22 Oct Wednesday 0730 REGISTRATION 0830 OPENING 0900 PLENARY

More information

30-31. Advancesincancer immunologyand immunotherapy. announcement. October2015. Royal Olympic Hotel Athens

30-31. Advancesincancer immunologyand immunotherapy. announcement. October2015. Royal Olympic Hotel Athens Advancesincancer immunologyand immunotherapy 30-31 October2015 Royal Olympic Hotel Athens announcement Organizer Hellenic Oncology Research Group (HORG) Symposium chairs N. Kentepozidis, A. Kotsakis, M.

More information

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine

Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine Support Program for Improving Graduate School Education Advanced Education Program for Integrated Clinical, Basic and Social Medicine January 27, 2009 Dear Professors (representative) of departments, Subject:

More information

EMA and Progressive Multifocal Leukoencephalopathy.

EMA and Progressive Multifocal Leukoencephalopathy. EMA and Progressive Multifocal Leukoencephalopathy. ENCePP Plenary, London 23 November 2011 Presented by: Henry Fitt Head of Coordination & Networking, Pharmacovigilance & Risk Management An agency of

More information

NEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY. Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds

NEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY. Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds NEW CLINICAL RESEARCH OPTIONS IN PANCREATIC CANCER IMMUNOTHERAPY Alan Melcher Professor of Clinical Oncology and Biotherapy Leeds CANCER IMMUNOTHERAPY - Breakthrough of the Year in Science magazine 2013.

More information

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials

LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials LEUKEMIA LYMPHOMA MYELOMA Advances in Clinical Trials OUR FOCUS ABOUT emerging treatments Presentation for: Judith E. Karp, MD Advancements for Acute Myelogenous Leukemia Supported by an unrestricted educational

More information

BioMmune Technologies Inc. Corporate Presentation 2015

BioMmune Technologies Inc. Corporate Presentation 2015 BioMmune Technologies Inc Corporate Presentation 2015 * Harnessing the body s own immune system to fight cancer & other autoimmune diseases BioMmune Technologies Inc. (IMU) ABOUT A public biopharmaceutical

More information

Immunology in pathology (immunopathology) Patology. immunology in pathology. immunologic response. lecture 3

Immunology in pathology (immunopathology) Patology. immunology in pathology. immunologic response. lecture 3 Patology Immunology in pathology (immunopathology) lecture 3 prof. dr hab. n. med. Andrzej Marszałek immunology in pathology Diseases with immunologic mechanism of tissue injury. Hypersensitivity reactions:

More information

This presentation may contain forward-looking statements, which reflect Trillium's current expectation regarding future events. These forward-looking

This presentation may contain forward-looking statements, which reflect Trillium's current expectation regarding future events. These forward-looking Q1/2016 This presentation may contain forward-looking statements, which reflect Trillium's current expectation regarding future events. These forward-looking statements involve risks and uncertainties

More information

The Lymphatic System

The Lymphatic System The Lymphatic System Transports escaped fluids back to the blood Plays essential roles in body defense and resistance to disease Lymph excess tissue fluid carried by lymphatic vessels Properties of lymphatic

More information

SYMPOSIUM. June 15, 2013. Photonics Center Colloquium Room (906) 8 Saint Mary's St., Boston, MA 02215 Boston University

SYMPOSIUM. June 15, 2013. Photonics Center Colloquium Room (906) 8 Saint Mary's St., Boston, MA 02215 Boston University SYMPOSIUM June 15, 2013 Photonics Center Colloquium Room (906) 8 Saint Mary's St., Boston, MA 02215 Bette Korber Los Alamos National Labs HIV evolution and the neutralizing antibody response We have recently

More information

2) Macrophages function to engulf and present antigen to other immune cells.

2) Macrophages function to engulf and present antigen to other immune cells. Immunology The immune system has specificity and memory. It specifically recognizes different antigens and has memory for these same antigens the next time they are encountered. The Cellular Components

More information

LESSON 3: ANTIBODIES/BCR/B-CELL RESPONSES

LESSON 3: ANTIBODIES/BCR/B-CELL RESPONSES Introduction to immunology. LESSON 3: ANTIBODIES/BCR/B-CELL RESPONSES Today we will get to know: The antibodies How antibodies are produced, their classes and their maturation processes Antigen recognition

More information

Understanding the immune response to bacterial infections

Understanding the immune response to bacterial infections Understanding the immune response to bacterial infections A Ph.D. (SCIENCE) DISSERTATION SUBMITTED TO JADAVPUR UNIVERSITY SUSHIL KUMAR PATHAK DEPARTMENT OF CHEMISTRY BOSE INSTITUTE 2008 CONTENTS Page SUMMARY

More information

INSERM/ A. Bernheim. Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance

INSERM/ A. Bernheim. Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance A. Bernheim Overcoming clinical relapse in multiple myeloma by understanding and targeting the molecular causes of drug resistance OVER-MyR is funded by the European Commission within its FP7 specific

More information

Overview of Phase 1 Oncology Trials of Biologic Therapeutics

Overview of Phase 1 Oncology Trials of Biologic Therapeutics Overview of Phase 1 Oncology Trials of Biologic Therapeutics Susan Jerian, MD ONCORD, Inc. February 28, 2008 February 28, 2008 Phase 1 1 Assumptions and Ground Rules The goal is regulatory approval of

More information

Hapten - a small molecule that is antigenic but not (by itself) immunogenic.

Hapten - a small molecule that is antigenic but not (by itself) immunogenic. Chapter 3. Antigens Terminology: Antigen: Substances that can be recognized by the surface antibody (B cells) or by the TCR (T cells) when associated with MHC molecules Immunogenicity VS Antigenicity:

More information

Future Oncology: Technology, Products, Market and Service Opportunities

Future Oncology: Technology, Products, Market and Service Opportunities Brochure More information from http://www.researchandmarkets.com/reports/296370/ Future Oncology: Technology, Products, Market and Service Opportunities Description: Future Oncology is an analytical newsletter

More information

Test 4 Immune System (Chapters 20 & 21)

Test 4 Immune System (Chapters 20 & 21) Test 4 Immune System (Chapters 20 & 21) Name: Date: 1) The is the largest lymphoid organ. 1) A. lymph node B. spleen C. thymus D. tonsil 2) Tonsils promote memory of pathogens by. 2) A. secreting antibodies

More information

A disease and antibody biology approach to antibody drug discovery

A disease and antibody biology approach to antibody drug discovery A disease and antibody biology approach to antibody drug discovery Björn Frendéus, PhD VP, Preclinical research Presenter: Björn Frendéus Date: 2011-11-08 1 Antibodies have revolutionized Cancer Treatment!

More information

Understanding How Existing and Emerging MS Therapies Work

Understanding How Existing and Emerging MS Therapies Work Understanding How Existing and Emerging MS Therapies Work This is a promising and hopeful time in the field of multiple sclerosis (MS). Many new and different therapies are nearing the final stages of

More information

Overview. Transcriptional cascades. Amazing aspects of lineage plasticity. Conventional (B2) B cell development

Overview. Transcriptional cascades. Amazing aspects of lineage plasticity. Conventional (B2) B cell development Overview B cell development Transcriptional cascades Amazing aspects of lineage plasticity Conventional (B2) B cell development What happens to an autoreactive B cell? B1 vs B2 cells Key anatomical sites

More information

Immunity and Abnormal Responses. Immune System. The Normal Immune Response. Bio 375. Pathophysiology

Immunity and Abnormal Responses. Immune System. The Normal Immune Response. Bio 375. Pathophysiology Immunity and Abnormal Responses Bio 375 Pathophysiology Immune System The immune system is a major component of the body s defenses It is a SPECIFIC defense, responding to particular substances: Cells

More information

Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Microbiology, Immunology and Serology

Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Microbiology, Immunology and Serology Course Curriculum for Master Degree in Medical Laboratory Sciences/Clinical Microbiology, Immunology and Serology The Master Degree in Medical Laboratory Sciences / Clinical Microbiology, Immunology or

More information

Lymph capillaries, Lymphatic collecting vessels, Valves, Lymph Duct, Lymph node, Vein

Lymph capillaries, Lymphatic collecting vessels, Valves, Lymph Duct, Lymph node, Vein WLHS/A&P/Oppelt Name Lymphatic System Practice 1. Figure 12-1 provides an overview of the lymphatic vessels. First color code the following structures. Color code in Figure 12-1 Heart Veins Lymphatic vessels/lymph

More information

About B Cell Lymphomas Groupmeeting Klipp/Spang, December 09 2002 Dennis Kostka Max-Planck-Institute for Molecular Genetics Computational Molecular Biology Berlin 1 Overview Short History of Lymphoma Classification

More information

Autoimmunity. Autoimmunity. Genetic Contributions to Autoimmunity. Targets of Autoimmunity

Autoimmunity. Autoimmunity. Genetic Contributions to Autoimmunity. Targets of Autoimmunity Autoimmunity Factors predisposing an individual to autoimmune disease Mechanisms of initiation of autoimmunity Pathogenesis of particular autoimmune disease Animal models of autoimmune disease Treatment

More information

Rheumatoid arthritis: an overview. Christine Pham MD

Rheumatoid arthritis: an overview. Christine Pham MD Rheumatoid arthritis: an overview Christine Pham MD RA prevalence Chronic inflammatory disease affecting approximately 0.5 1% of the general population Prevalence is higher in North America (approaching

More information

OKT3. ~ The first mouse monoclonal antibody. used in clinical practice in the field of transplantation ~

OKT3. ~ The first mouse monoclonal antibody. used in clinical practice in the field of transplantation ~ g944202 潘 怡 心 OKT3 ~ The first mouse monoclonal antibody used in clinical practice in the field of transplantation ~ As everybody knows, OKT3 is the first mouse monoclonal antibody produced for the treatment

More information

Micro 204 Tumor Immunology.

Micro 204 Tumor Immunology. Micro 204 Tumor Immunology Lewis.Lanier@ucsf.edu Immunological Surveillance Ehrlich, Burnet & Thomas Paul Ehrlich (1909) Concept of cancer immunosurveillance. Predicted that cancer would occur at incredible

More information

Ph.D. in Molecular Medicine

Ph.D. in Molecular Medicine Ph.D. in Molecular Medicine and Translational Research College of Medicine 1. Introduction: The College of Medicine, while consolidating on its undergraduate innovative educational programs, decided to

More information

The Immune System. 2 Types of Defense Mechanisms. Lines of Defense. Line of Defense. Lines of Defense

The Immune System. 2 Types of Defense Mechanisms. Lines of Defense. Line of Defense. Lines of Defense The Immune System 2 Types of Defense Mechanisms Immune System the system that fights infection by producing cells to inactivate foreign substances to avoid infection and disease. Immunity the body s ability

More information

Curriculum for Structured Doctoral Candidate Training at the Heinrich Pette Institute Leibniz Institute for Experimental Virology

Curriculum for Structured Doctoral Candidate Training at the Heinrich Pette Institute Leibniz Institute for Experimental Virology Curriculum for Structured Doctoral Candidate Training at the Heinrich Pette Institute Leibniz Institute for Experimental Virology Please choose lectures and courses according to your interests and requirements.

More information

Modelling and analysis of T-cell epitope screening data.

Modelling and analysis of T-cell epitope screening data. Modelling and analysis of T-cell epitope screening data. Tim Beißbarth 2, Jason A. Tye-Din 1, Gordon K. Smyth 1, Robert P. Anderson 1 and Terence P. Speed 1 1 WEHI, 1G Royal Parade, Parkville, VIC 3050,

More information

Core Topic 2. The immune system and how vaccines work

Core Topic 2. The immune system and how vaccines work Core Topic 2 The immune system and how vaccines work Learning outcome To be able to describe in outline the immune system and how vaccines work in individuals and populations Learning objectives Explain

More information

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons

LYMPHOMA. BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons LYMPHOMA BACHIR ALOBEID, M.D. HEMATOPATHOLOGY DIVISION PATHOLOGY DEPARTMENT Columbia University/ College of Physicians & Surgeons Normal development of lymphocytes Lymphocyte proliferation and differentiation:

More information

One of the more complex systems we re looking at. An immune response (a response to a pathogen) can be of two types:

One of the more complex systems we re looking at. An immune response (a response to a pathogen) can be of two types: Immune system. One of the more complex systems we re looking at. An immune response (a response to a pathogen) can be of two types: (pathogen - disease causing organism) 1) Non specific. Anything foreign

More information

ELISA BIO 110 Lab 1. Immunity and Disease

ELISA BIO 110 Lab 1. Immunity and Disease ELISA BIO 110 Lab 1 Immunity and Disease Introduction The principal role of the mammalian immune response is to contain infectious disease agents. This response is mediated by several cellular and molecular

More information

Contents. Prefacce xi List of Contributors xiii

Contents. Prefacce xi List of Contributors xiii V Contents Prefacce xi List of Contributors xiii 1 Peptides as Drugs: Discovery and Development 1 Bernd Groner 1.1 Discovery of New Potential Drug Targets and the Limitations of Druggability 1 1.2 Protein

More information

FASEB Directory of Members Online

FASEB Directory of Members Online Head, Department of Anatomy and Radiology The College of Veterinary Medicine at the University of Georgia invites nominations and applications for the position of Head of the Department of Anatomy and

More information

BVIG/SBMI Meeting 2007. Bart N. Lambrecht, MD, PhD. Department of Respiratory Diseases University Hospital Gent, Belgium

BVIG/SBMI Meeting 2007. Bart N. Lambrecht, MD, PhD. Department of Respiratory Diseases University Hospital Gent, Belgium Dendritic cells : from bench to bedside BVIG/SBMI Meeting 2007 Bart N. Lambrecht, MD, PhD Department of Respiratory Diseases University Hospital Gent, Belgium Outline Role of DCs in the immune system Role

More information

Chapter 18: Applications of Immunology

Chapter 18: Applications of Immunology Chapter 18: Applications of Immunology 1. Vaccinations 2. Monoclonal vs Polyclonal Ab 3. Diagnostic Immunology 1. Vaccinations What is Vaccination? A method of inducing artificial immunity by exposing

More information

Corporate Medical Policy

Corporate Medical Policy Corporate Medical Policy Hematopoietic Stem-Cell Transplantation for CLL and SLL File Name: Origination: Last CAP Review: Next CAP Review: Last Review: hematopoietic_stem-cell_transplantation_for_cll_and_sll

More information

Innate Immunity: Nonspecific Defenses of the Host

Innate Immunity: Nonspecific Defenses of the Host 16 Innate Immunity: Nonspecific Defenses of the Host SLOs Differentiate between innate and adaptive immunity. Define toll-like receptors. Differentiate physical from chemical factors, and list examples

More information

Immunology and immunotherapy in allergic disease

Immunology and immunotherapy in allergic disease Immunology and immunotherapy in allergic disease Jing Shen, MD Faculty Advisor: Matthew Ryan, MD The University of Texas Medical Branch Department of Otolaryngology Grand Rounds Presentation February 2005

More information

T Cell Maturation,Activation and Differentiation

T Cell Maturation,Activation and Differentiation T Cell Maturation,Activation and Differentiation Positive Selection- In thymus, permits survival of only those T cells whose TCRs recognize self- MHC molecules (self-mhc restriction) Negative Selection-

More information

2014 CORPORATE OVERVIEW

2014 CORPORATE OVERVIEW 2014 CORPORATE OVERVIEW Applied Immunology provides custom assay services to support the development of therapeutics, vaccines and diagnostics. 2014 CORPORATE OVERVIEW 2 OUR FOCUS Applications: Immuno-oncology

More information

MULTIPLE MYELOMA. Dr Malkit S Riyat. MBChB, FRCPath(UK) Consultant Haematologist

MULTIPLE MYELOMA. Dr Malkit S Riyat. MBChB, FRCPath(UK) Consultant Haematologist MULTIPLE MYELOMA Dr Malkit S Riyat MBChB, FRCPath(UK) Consultant Haematologist Multiple myeloma is an incurable malignancy that arises from postgerminal centre, somatically hypermutated B cells.

More information

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can

treatments) worked by killing cancerous cells using chemo or radiotherapy. While these techniques can Shristi Pandey Genomics and Medicine Winter 2011 Prof. Doug Brutlag Chronic Myeloid Leukemia: A look into how genomics is changing the way we treat Cancer. Until the late 1990s, nearly all treatment methods

More information

Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs

Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer Drugs Provisional Translation (as of January 27, 2014)* November 15, 2013 Pharmaceuticals and Bio-products Subcommittees, Science Board Summary of Discussion on Non-clinical Pharmacology Studies on Anticancer

More information

Cytokines: Physiology and Clinical Relevance Pranay D. Khare, Ph.D. and Meenakshi Khare, Ph.D.

Cytokines: Physiology and Clinical Relevance Pranay D. Khare, Ph.D. and Meenakshi Khare, Ph.D. Cytokines: Physiology and Clinical Relevance Pranay D. Khare, Ph.D. and Meenakshi Khare, Ph.D. A shift in medicine is taking place. It is characterized by the emergence of neuroendoimmunology (NEI), a

More information